Bleeding between periods — is it normal?

Bleeding that occurs between menstrual periods — often called intermenstrual bleeding or spotting — is a relatively common complaint among people with a uterus. The clinical significance ranges from a benign, self-limited event to an indication of a serious underlying disorder. This article reviews definitions, common causes, clinical evaluation, red flags requiring urgent care, diagnostic testing, and evidence-based treatment options. Recommendations and background information are drawn from professional sources including ACOG, NIH/MedlinePlus, Mayo Clinic, and Cleveland Clinic.

Definitions and terminology

Intermenstrual bleeding (spotting): light bleeding or spotting that occurs at any time between expected menstrual periods.
Metrorrhagia: historically used to describe bleeding occurring at irregular intervals outside the expected cycle. In contemporary practice, the term abnormal uterine bleeding (AUB) is preferred and is classified by clinical pattern and cause.
Menorrhagia: heavy or prolonged menstrual bleeding (excessive menstrual blood loss).
Dysfunctional uterine bleeding: older term referring to abnormal bleeding not explained by structural lesions or systemic disease; today evaluated as part of the AUB framework.

Although many people experience an isolated episode of spotting that is not clinically significant, recurrent or heavy intermenstrual bleeding warrants medical evaluation to establish a cause and appropriate management [ACOG; Mayo Clinic].

Is it ever “normal”?

Yes — occasional, light spotting can be physiologic in specific settings:

Ovulatory spotting: light midcycle spotting can occur around ovulation in some people, likely related to hormonal fluctuations.
Implantation bleeding: light spotting may occur early in pregnancy around the time of implantation, although not everyone experiences it.
Starting, stopping, or changing hormonal contraception: breakthrough bleeding or spotting is common in the first few months after beginning combined oral contraceptives, progestin-only pills, contraceptive implants, or injectable contraceptives. The bleeding often resolves with time or with adjustment of method [ACOG; Mayo Clinic].
Adolescence and perimenopause: these life stages are frequently associated with irregular cycles and intermenstrual bleeding because of immature or fluctuating ovulatory function.

However, “normal” only applies to light, short-lived bleeding in the contexts above. Recurrent, heavy, prolonged, or symptomatic intermenstrual bleeding is not normal and requires medical evaluation.

How clinicians think about abnormal bleeding

Professional organizations classify AUB by cause using the PALM-COEIN framework (structural vs nonstructural causes):

PALM — structural causes:
P: Polyps (endometrial or cervical)
A: Adenomyosis
L: Leiomyoma (fibroids)
M: Malignancy and hyperplasia

COEIN — nonstructural causes:
C: Coagulopathy (bleeding disorders)
O: Ovulatory dysfunction (anovulation, oligo-ovulation)
E: Endometrial causes (primary disorders of endometrial hemostasis)
I: Iatrogenic (medication-related, e.g., anticoagulants, hormone therapy)
N: Not yet classified

This framework helps guide evaluation and management [ACOG; NIH/MedlinePlus].

Common causes of bleeding between periods

Hormonal causes

Anovulation or irregular ovulation (common in adolescents, perimenopause, and with conditions such as polycystic ovary syndrome [PCOS])
Changes in endogenous hormones (stress, weight change, intense exercise)
Breakthrough bleeding from hormonal contraception (especially during the first 3 months)

Structural uterine or cervical lesions

Endometrial or cervical polyps
Uterine fibroids (leiomyomas) — submucosal fibroids can cause irregular bleeding that may resemble menstruation
Adenomyosis (endometrial tissue within the myometrium)
Endometrial hyperplasia or endometrial cancer (more concern with persistent bleeding or in older patients)

Pregnancy-related bleeding

Implantation bleeding
Miscarriage (spontaneous abortion)
Ectopic pregnancy
Molar pregnancy

Infection and inflammation

Cervicitis (including sexually transmitted infections)
Endometritis (uterine infection), including following instrumentation or delivery

Systemic and hematologic causes

Bleeding disorders (e.g., von Willebrand disease)
Medications (anticoagulants, antiplatelet agents)
Thyroid dysfunction and other systemic illnesses

Iatrogenic causes

Intrauterine device (IUD) — copper devices commonly associated with heavier bleeding; levonorgestrel intrauterine systems commonly associated with irregular spotting initially but often decrease overall bleeding long-term
Recent gynecologic procedures (biopsy, dilation and curettage)

Malignancy

Endometrial or cervical cancer — particularly important to consider in postmenopausal bleeding or persistent abnormal bleeding in older patients

When to seek immediate medical attention

Seek emergency care (visit the emergency department) if you have any of the following:

Very heavy bleeding that soaks through a pad or tampon in less than an hour or is associated with large clots
Signs of hemodynamic instability: dizziness, fainting or near-syncope, lightheadedness, rapid heartbeat (tachycardia), low blood pressure, shortness of breath
Severe pelvic or abdominal pain
Fever or other signs of infection
Pregnancy with any significant bleeding or severe pain

These symptoms may indicate severe acute blood loss, infection, or pregnancy complications (including ectopic pregnancy) and require urgent assessment [Mayo Clinic; Cleveland Clinic].

Clinical evaluation

A targeted clinical evaluation identifies likely causes and guides testing.

History

Characterize the bleeding: timing (when did it start? how many days?), amount (pad/tampon use, clots), pattern (isolated episode vs recurrent), color (spotting vs bright red), associated symptoms (pain, fever, discharge)
Menstrual history: cycle length, regularity, usual flow, first day of last menstrual period
Reproductive history: pregnancies, recent pregnancy, contraceptive use, recent gynecologic procedures
Sexual history, risk of sexually transmitted infections
Medications: anticoagulants, hormonal therapies
Systemic symptoms: weight change, fatigue, easy bruising, family history of bleeding disorders
Age-related considerations: adolescence, perimenopause, postmenopause

Physical examination

Vital signs (to assess hemodynamic stability)
Abdominal and pelvic exam: visual inspection of vulva and vagina, speculum exam to evaluate the cervix and bleeding source, bimanual exam to assess uterine size and adnexal tenderness or masses
Consider pelvic cultures if infection suspected

Initial laboratory and imaging tests

Pregnancy test (urine hCG) — mandatory in any person of reproductive potential with uterine bleeding
Complete blood count (CBC) to evaluate hemoglobin/hematocrit and quantify blood loss/anemia
Coagulation studies if bleeding disorder suspected or on anticoagulation
Testing for sexually transmitted infections if cervicitis is suspected
Thyroid function tests if clinically indicated
Transvaginal ultrasound (first-line imaging for structural causes such as polyps, fibroids, focal endometrial thickening)
Endometrial sampling (biopsy) for women ≥35 years with AUB or in younger women with risk factors for endometrial hyperplasia/cancer; indicated for persistent intermenstrual bleeding [ACOG; NIH MedlinePlus; Mayo Clinic]

Additional evaluation (when indicated)

Hysteroscopy for direct visualization and potential removal of intrauterine polyps or submucosal fibroids
Sonohysterography to better delineate intrauterine lesions
Specialized coagulation testing (von Willebrand panel) in adolescents with heavy menstrual bleeding or patients with bleeding history

Special populations

Adolescents

The most common cause of intermenstrual and heavy bleeding in adolescents is anovulatory cycles due to immaturity of the hypothalamic-pituitary-ovarian axis.
Evaluate for coagulopathies in adolescents with heavy or prolonged bleeding, especially with a personal or family history of bleeding disorders [ACOG; NIH].

Perimenopausal and postmenopausal patients

Perimenopause is commonly associated with irregular bleeding due to fluctuating ovulation.
Any postmenopausal bleeding is abnormal and requires evaluation to exclude endometrial cancer or hyperplasia. Transvaginal ultrasound to measure endometrial thickness and endometrial biopsy are commonly performed [ACOG; Mayo Clinic].

Pregnancy

Always perform a pregnancy test in reproductive-age patients with intermenstrual bleeding.
Any bleeding in early pregnancy warrants prompt medical evaluation for threatened miscarriage or ectopic pregnancy.

Common treatment options by cause

Treatment is individualized, based on the underlying cause, severity, patient age, fertility desires, and coexisting medical conditions. Below are commonly used medical and procedural options.

Medical therapies

Tranexamic acid (antifibrinolytic)
Effective for reducing heavy menstrual bleeding from benign causes.
Typical oral regimen: 1 gram three times daily (3 g/day) during bleeding episodes, up to 3–5 days. Use is contraindicated in patients with active thromboembolic disease and caution is needed in those with a history of thrombosis [Mayo Clinic; Cleveland Clinic].

Nonsteroidal anti-inflammatory drugs (NSAIDs)
NSAIDs (ibuprofen, naproxen) can reduce menstrual blood loss by inhibiting prostaglandin synthesis and provide analgesia.
Useful for ovulatory-related heavy bleeding and dysmenorrhea; less effective for structural lesions.

Hormonal therapies
Combined oral contraceptives (COCs): useful for cycle regulation and reduction of intermenstrual bleeding due to ovulatory dysfunction or as short-term treatment for acute heavy bleeding. Breakthrough bleeding is common initially but often improves over several months.
Progestin therapy: oral progestins (e.g., medroxyprogesterone acetate), injectable progestins, or the levonorgestrel intrauterine system (LNG-IUS) may control bleeding. The LNG-IUS (e.g., Mirena®) is effective for long-term reduction of heavy menstrual bleeding and can be an alternative to hysterectomy for benign causes.
High-dose estrogen or progestin regimens are sometimes used acutely to stabilize severe bleeding in the outpatient or inpatient setting; such regimens should be managed by clinicians familiar with their indications and contraindications [ACOG].

Management of underlying systemic disease
Treat thyroid dysfunction, correct coagulation abnormalities, or adjust anticoagulant therapy in consultation with the prescribing clinician or hematologist.

Procedural and surgical therapies

Polypectomy (hysteroscopic removal): recommended for symptomatic endometrial polyps causing intermenstrual bleeding.
Myomectomy: surgical removal of fibroids for symptomatic leiomyomas in patients who desire future fertility.
Endometrial ablation: an option for patients with heavy uterine bleeding who have completed childbearing; ablation reduces menstrual flow but is not appropriate for those who may wish to conceive.
Hysterectomy: definitive treatment for refractory AUB or when structural disease and symptoms cannot be managed with conservative measures; considered after discussion of risks, alternatives, and fertility desires.
Hysteroscopy with directed sampling: both diagnostic and therapeutic for intrauterine lesions.
Management of pregnancy-related causes: evaluation and treatment of miscarriage, ectopic pregnancy, or other pregnancy complications per obstetrical protocols.

Practical approach: an outpatient algorithm

Stabilize if hemodynamically unstable — resuscitation, IV fluids, blood transfusion as needed; urgent gynecologic consultation.
Obtain pregnancy test in any person of reproductive potential.
If pregnancy-negative and bleeding is not life-threatening:

Obtain CBC, consider STI testing, and perform pelvic exam.
Transvaginal ultrasound to evaluate for structural causes.
If endometrial thickness or clinical suspicion warrants, perform endometrial sampling or refer for hysteroscopy.

Initiate medical therapy as appropriate:

For acute heavy bleeding in a stable patient, options include tranexamic acid, NSAIDs, or hormonal therapy (COCs or high-dose progestins), guided by clinician assessment and contraindications.
For recurrent intermenstrual bleeding related to contraception, reassure and counsel on expected course, unless bleeding persists beyond 3 months or is heavy.

Refer for specialty care (gynecology) if structural lesions are identified, bleeding persists despite treatment, or cancer is suspected.

When malignancy is a concern

Persistent intermenstrual bleeding, especially in patients over age 35 or in those with risk factors (obesity, unopposed estrogen exposure, Lynch syndrome), necessitates evaluation for endometrial hyperplasia or cancer. Endometrial biopsy is the primary outpatient test to obtain tissue for histologic diagnosis. Transvaginal ultrasonography can assist in assessing endometrial thickness. Any postmenopausal bleeding requires prompt assessment [ACOG; NIH; Mayo Clinic].

Bleeding related to contraception

Combined hormonal contraceptives: bleeding/spotting is common during the first 3 months and often resolves. If bleeding is heavy, prolonged, or persists beyond 3 months, assess for other causes and consider changing the regimen.
Progestin-only methods: irregular bleeding is a common side effect; options for management include expectant management, switching methods, or adding short courses of estrogen in select cases under clinician guidance.
Intrauterine devices:
Copper IUD: may cause heavier menstrual bleeding and cramping, particularly in the first months.
Levonorgestrel IUD: frequently reduces menstrual bleeding over time and may be therapeutic for heavy menstrual bleeding related to benign causes.

Bleeding disorders and menorrhagia

Up to one-quarter of adolescents with heavy menstrual bleeding have an underlying bleeding disorder, most commonly von Willebrand disease. A high suspicion is warranted when heavy bleeding begins with menarche, there is a family history of bleeding disorders, or when bleeding is disproportionate to other clinical findings. Hematology consultation and appropriate laboratory testing should be arranged [ACOG; NIH].

Counseling, monitoring, and follow-up

Keep a menstrual diary: record dates, bleeding amount, associated symptoms, contraceptive use, and any treatments. This aids diagnostic evaluation and monitoring of response to therapy.
Follow-up for persistent or recurrent bleeding: if intermenstrual bleeding recurs more than once or is associated with systemic symptoms (fatigue, syncope, anemia), seek medical evaluation.
Discuss fertility and contraception goals: treatment selection often depends on whether the patient wishes to preserve fertility.
Address lifestyle factors: weight management, smoking cessation, and control of chronic medical conditions can influence menstrual regularity.

Takeaway — is bleeding between periods normal?

Light, transient spotting in specific contexts (ovulation, early contraception use, implantation) can be physiologic and self-limited. However, recurrent, heavy, prolonged, or symptomatic intermenstrual bleeding is not normal and should prompt clinical evaluation. A careful history, pregnancy testing, examination, and targeted testing (ultrasound, laboratory studies, endometrial sampling) allow clinicians to identify common causes — hormonal, structural, infectious, systemic, medication-related, or malignant — and to provide appropriate medical or procedural treatment. Immediate medical attention is required for heavy bleeding with hemodynamic instability, severe pain, or fever.

If you experience bleeding between periods more than once, or if the bleeding is heavy or associated with symptoms such as dizziness, fainting, or severe pain, consult your healthcare provider or seek urgent care.

References and resources

American College of Obstetricians and Gynecologists (ACOG). Abnormal Uterine Bleeding. Patient FAQs and Practice Bulletins. https://www.acog.org/womens-health/faqs/abnormal-uterine-bleeding
National Institutes of Health — MedlinePlus. Abnormal uterine bleeding. https://medlineplus.gov/abnormaluterinebleeding.html
Mayo Clinic. Abnormal uterine bleeding — Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/abnormal-uterine-bleeding/symptoms-causes/syc-20355278
Cleveland Clinic. Abnormal uterine bleeding. https://my.clevelandclinic.org/health/diseases/15476-abnormal-uterine-bleeding

(These sources provide comprehensive, patient-centered information and reflect current clinical approaches to evaluation and management of intermenstrual and abnormal uterine bleeding.)